[Hot Stock] LaserOptek Surges on News of World’s First Triple-Wavelength Laser System FDA Approval
![[Hot Stock] LaserOptek Surges on News of World’s First Triple-Wavelength Laser System FDA Approval](http://www.asiae.co.kr/news/img_view.htm?img=2024072208164559128_1721603806.jpg)
LaserOptek is showing strong performance. This is attributed to the news that its laser device for pigment disease treatment, 'Helios 785,' has obtained premarket approval (510k) from the U.S. Food and Drug Administration (FDA).
As of 9:30 AM on the 11th, LaserOptek is trading at 7,870 KRW, up 22.97% compared to the previous day.
The FDA's 510(k) is an approval system that verifies the safety and effectiveness of a medical device by comparing it to an existing certified product before market release.
LaserOptek's Helios series is a device used for treating various pigment disorders including melasma, whitening, removal of various color tattoos, toning, and is supplied to over 40 countries worldwide.
Hot Picks Today
Despite "Insufficient Balance" Notices, They Board Anyway... Reports of Foreign Fare Evasion Mounting
- A "Rich Family's Daughter" Is "Effortlessly Polished" Today, "Glamorous" Tomorrow... Department Store-Core Has 20- and 30-Somethings Going Wild [Why&Next]
- "Even Underwear Has to Be Cut Up with Scissors"... China Hit by Rise of "Trash Hunters" in an "If You're Slow, You're Out" Scramble
- "If You Don't Buy Now, You Can't Get It at This Price": Koreans Fill the Void Left by Chinese Tourists, Spend Big in Japan
- "Photos of Kim Jong Un Released by North Korea Are a Deception"... Debate Over Death Rumors Continues
The latest product in the Helios series, the Helios 785 laser, features triple wavelengths of 785/1064/532nm and integrates pico and nano lasers on one platform. It is known to minimize side effects and provide safe treatment tailored to various skin types, specializing in pigment treatment.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
